Showing results (281-290 of 348) with videos related to
Sort By:
Pageof 35
Leukemia|March 8, 2019
Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.Leukemia|September 11, 2009
The use of novel agents in the treatment of relapsed and refractory multiple myelomaJ P Laubach, A Mahindra, C S Mitsiades, et al.Leukemia|March 16, 2011
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast functionS Vallet, S Pozzi, K Patel, et al.Leukemia|April 29, 2005
Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogsS Kumar, N Raje, T Hideshima, et al.Transfusion|May 1, 1994
Guidelines for blood utilization reviewL Stehling, N L Luban, K C Anderson, et al.Leukemia|December 20, 2017
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyondC S Chim, S K Kumar, R Z Orlowski, et al.Blood|April 15, 1991
Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignanciesS N Rabinowe, R J Soiffer, N J Tarbell, et al.Blood|April 1, 1993
Experiences of the first 493 unrelated marrow donors in the National Marrow Donor ProgramD F Stroncek, P V Holland, G Bartch, et al.Current Cancer Drug Targets|January 21, 2011
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trialsB C Potts, M X Albitar, K C Anderson, et al.Seminars in Oncology|November 24, 1999
Treatment of plasma cell dyscrasias by antibody-mediated immunotherapyS P Treon, Y Shima, F I Preffer, et al.Pageof 35